Abstract
Gene therapy in the central nervous system (CNS) is hindered by the presence of the blood–brain barrier, which restricts access of serum constituents and peripheral cells to the brain parenchyma. Expression of exogenously administered genes in the CNS has been achieved in vivo using highly invasive routes, or ex vivo relying on the direct implantation of genetically modified cells into the brain. Here we provide evidence for a novel, noninvasive approach for targeting potential therapeutic factors to the CNS. Genetically-modified hematopoietic cells enter the CNS and differentiate into microglia after bone-marrow transplantation. Up to a quarter of the regional microglial population is donor-derived by four months after transplantation. Microglial engraftment is enhanced by neuropathology, and gene-modified myeloid cells are specifically attracted to the sites of neuronal damage. Thus, microglia may serve as vehicles for gene delivery to the nervous system.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Novel Microglia-based Therapeutic Approaches to Neurodegenerative Disorders
Neuroscience Bulletin Open Access 03 January 2023
-
Targeted BRD4 protein degradation by dBET1 ameliorates acute ischemic brain injury and improves functional outcomes associated with reduced neuroinflammation and oxidative stress and preservation of blood–brain barrier integrity
Journal of Neuroinflammation Open Access 27 June 2022
-
Functional role of brain-engrafted macrophages against brain injuries
Journal of Neuroinflammation Open Access 15 October 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kreutzberg, G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19, 312–318 (1996).
Eglitis, M.A. & Mezey, É. Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc. Natl. Acad. Sci. USA 94, 4080–4085 (1997).
Brazelton, T.R., Rossi, F.M.V., Keshet, G.I. & Blau, H.M. From marrow to brain: expression of neuronal phenotypes in adult mice. Science 290, 1775–1779 (2000).
Mezey, É, Chandross, K.J., Harta, G., Maki, R.A. & McKercher, S.R. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 290, 1779–1782 (2000).
Persons, D.A. et al. Retroviral-mediated transfer of the green fluorescent protein gene into murine hematopoietic cells facilitates scoring and selection of transduced progenitors in vitro and identification of genetically modified cells in vivo. Blood 90, 1777–1786 (1997).
Pawliuk, R., Eaves, C. & Humphries, R. Sustained high-level reconstitution of the hematopoietic system by preselected hematopoietic cells expressing a transduced cell-surface antigen. Hum. Gene Ther. 8, 1595–1604 (1997).
Okabe, M., Ikawa, M., Kominami, K., Nakanishi, T. & Nishimune, Y. Green mice as a source of ubiquitous green cells. FEBS Lett. 407, 313–319 (1997).
Imai, Y. et al. A novel gene Iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage. Biochem. Biophys. Res. Commun. 224, 855–862 (1996).
Carson, M.J., Reilly, C.R., Sutcliffe, J.G. & Lo, D. Mature microglia resemble immature antigen-presenting cells Glia 22, 72–85 (1998).
Hollerbach, E.H., Haas, C.A., Hildebrandt, H., Frotscher, M. & Naumann, T. Region-specific activation of microglial cells in the rat septal complex following fimbria-fornix transection. J. Comp. Neurol. 390, 481–496 (1998).
Kennedy, D.W. & Abkowitz, J.L. Mature monocytic cells enter tissues and engraft. Proc. Natl. Acad. Sci. USA 95, 14944–14949 (1998).
Lagasse, E. et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nature Med. 6, 1229–1234 (2000).
Orlic, D. et al. Bone marrow cells regenerate infarcted myocardium. Nature 410, 701–705 (2001).
Krall, W.J. et al. Cells expressing human glucocerebrosidase from a retroviral vector repopulate macrophages and central nervous system microglia after murine bone marrow transplantation. Blood 83, 2737–2748 (1994).
Hickey, W.F. & Kimura, H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239, 290–292 (1988).
Hickey, W.F., Vass, K. & Lassmann, H. Bone marrow-derived elements in the central nervous system: an immunohistochemical and ultrastructural survey of rat chimeras. J. Neuropathol. Exp. Neurol. 51, 246–256 (1992).
Goldman, S. & Roy, N. Human neural progenitor cells: better blue than green? Nature Med. 6, 483–484 (2000).
Kennedy, D.W. & Abkowitz, J.L. Kinetics of central nervous system microglial and macrophage engraftment: Analysis using a transgenic bone marrow transplantation model. Blood 90, 986–993 (1997).
Schlüter, D. et al. Regulation of microglia by CD4+ and CD8+ T cells: selective analysis in CD45-congenic normal and Toxoplasma gondii -infected bone marrow chimeras. Brain Pathol. 11, 44–55 (2001).
Lawson, L.J., Perry, V.H. & Gordon, S. Turnover of resident microglia in the normal adult mouse brain. Neuroscience 48, 405–415 (1992).
Burt, R.K. et al. Gene-marked autologous hematopoietic stem cell transplantation of autoimmune disease. J. Clin. Immunol. 20, 1–9 (2000).
Wu, Y.-P. et al. Distribution and characterization of GFP+ donor hematogenous cells in twitcher mice after bone marrow transplantation. Am. J. Pathol. 156, 1849–1854 (2000).
Wada, R., Tifft, C.J. & Proia, R.L. Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation. Proc. Natl. Acad. Sci. USA 97, 10954–10959 (2000).
Flügel, A. et al. Neuronal MCP-1 expression in response to remote nerve injury. J. Cereb. Blood Flow Metab. 21, 60–76 (2001).
Hara, H., Huang, P.L., Panahian, N., Fishman, M.C. & Moskowitz, M.A. Reduced brain edema and infraction in mice lacking the neuronal isoform of nitric oxide synthase after transient MCA occlusion. J. Cereb. Blood Flow Metab. 16, 605–611 (1996).
Acknowledgements
We thank P. Grämmel, D. Büringer, K. Brückner, S. Bauer and A. Sittler for their assistance. The work was partly supported by DFG and the Schilling foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Priller, J., Flügel, A., Wehner, T. et al. Targeting gene-modified hematopoietic cells to the central nervous system: Use of green fluorescent protein uncovers microglial engraftment. Nat Med 7, 1356–1361 (2001). https://doi.org/10.1038/nm1201-1356
Issue Date:
DOI: https://doi.org/10.1038/nm1201-1356
This article is cited by
-
Modified umbilical cord-blood transplantation for pediatric patients with mucopolysaccharidosis
Bone Marrow Transplantation (2023)
-
Novel Microglia-based Therapeutic Approaches to Neurodegenerative Disorders
Neuroscience Bulletin (2023)
-
Targeted BRD4 protein degradation by dBET1 ameliorates acute ischemic brain injury and improves functional outcomes associated with reduced neuroinflammation and oxidative stress and preservation of blood–brain barrier integrity
Journal of Neuroinflammation (2022)
-
Advanced therapeutic strategies targeting microglia: beyond neuroinflammation
Archives of Pharmacal Research (2022)
-
A phase I/IIa clinical trial of autologous hematopoietic stem cell transplantation in amyotrophic lateral sclerosis
Journal of Neurology (2022)